INNOSURFACE®
PLATFORM TECHNOLOGY
Our INNOSURFACE® Platform Technology is an advanced modular system that enables the structural integration of diverse therapeutic agents—including small molecules, proteins, and nanozymes (CORE)—with a broad range of biocompatible and deliverable surface materials such as polymers, liposomes, lipids, and silica (ENCAPSULATION). This flexible architecture allows for in-situ surface engineering and encapsulation, facilitating tailored nanomedicine formulation based on specific therapeutic needs.
Exclusively developed by OmniParticles, INNOSURFACE® revolutionizes nanomedicine by enabling precise assembly and modification at the interface of drug and delivery system. From laboratory-scale to commercial manufacturing, the platform ensures consistent quality and scalability, effectively addressing the challenge of maintaining nanoparticle uniformity.
Fully compliant with GMP standards, INNOSURFACE® supports regulatory readiness while offering a highly customizable framework—from therapeutic payload integration to surface chemistry tuning—meeting diverse clinical and formulation requirements with exceptional precision.
+
INNOSURFACE®
Surface control;
Stabilization & secondary efficacy :
e.g.) Polymer, Linker, Drugs, etc.
Nanocore;
Therapeutic functional core
Metal, Metal oxide
Components
CORE
Therapeutic core
Small molecules, Proteins, Nanozymes
ENCAPSULATION
┌
┐
Low M.W.
Stabilization & Ancillary therapeutic function
High M.W.
Additional stabilization & therapeutic function